Allergy Immunotherapy Market Outlook Driven by Environmental Pollution, Urbanization, and Increasing Allergic Disorders

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Allergy Immunotherapy Market Size, Share & Trends Analysis Report By Treatment Type (SCIT, SLIT), By Allergy Type (Allergic Rhinitis, Asthma), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), Region, Market Outlook And Industry Analysis 2034"

The global Allergy Immunotherapy market is estimated to reach over USD 4.3 Billion by the year 2034, exhibiting a CAGR of 8.5% during the forecast period.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1924

The anticipated revenue growth in the allergy therapeutics market is closely aligned with the increasing global prevalence of allergic diseases, which continue to place significant demands on healthcare systems. The rising incidence of complex allergic conditions, often associated with higher morbidity, is fueling heightened research and development efforts and the introduction of innovative treatment modalities.

Additionally, the surge in asthma and respiratory allergy cases is largely driven by deteriorating air quality resulting from both indoor and outdoor pollution. According to the Asthma and Allergy Foundation of America (AAFA), elevated pollen levels trigger allergic reactions in over 25 million individuals in the United States.

In Canada, data from the Canadian Allergy, Asthma, and Immunology Foundation indicate that allergic rhinitis affects approximately 20% to 25% of the population. Conventional symptomatic therapies are insufficient for nearly half of these patients, prompting pharmaceutical companies to explore advanced immunotherapy solutions. For instance, in 2019, ALK submitted an application to Canadian regulatory authorities seeking approval for its investigational sublingual immunotherapy (SLIT) tablet designed to treat tree pollen allergies.

List of Prominent Players in the Allergy Immunotherapy Market:
• ASIT Biotech
• Circassia
• Mylan N.V.
• Adamis Pharmaceuticals Corporation
• Merck KGaA
• Stallergenes Greer plc
• Allergy Therapeutics
• ALK-Abelló A/S
• DESENTUM OY
• HAL Allergy B.V.
• HollisterStier Allergy
• LETIPharma
• DBV Technologies SA

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-02

Market Dynamics
Drivers:
The global allergy immunotherapy market is projected to experience significant growth, driven primarily by the rising incidence and prevalence of allergic disorders. Data from the Centers for Disease Control and Prevention (CDC) indicate that, in 2018, hay fever affected approximately 19.2 million adults and 5.2 million children in the United States. Environmental factors, including increasing pollution levels and ongoing climate changes, are further contributing to market expansion.

According to the Asthma and Allergy Foundation of America (AAFA), more than 23 million individuals in the U.S. suffer from ragweed pollen allergies, which substantially reduce quality of life and can exacerbate asthma symptoms in patients with comorbid conditions.

Challenges:
Despite the clinical advantages of allergy immunotherapy, several barriers continue to limit widespread adoption, particularly regarding patient adherence and treatment affordability. Limited public awareness and constrained healthcare funding impede uptake. Research published by the National Center for Biotechnology Information (NCBI) in 2022 highlights that the time commitment associated with subcutaneous immunotherapy (SCIT), coupled with side effects from both SCIT and sublingual immunotherapy (SLIT), often results in treatment discontinuation.

In addition, the annual cost of allergy shots in the U.S. ranges from USD 1,600 to USD 4,000 for uninsured patients, and approximately USD 800 for insured individuals. Notably, SLIT formulations have not yet received FDA approval or insurance reimbursement in the U.S., restricting accessibility and limiting market penetration.

Regional Trends:
Europe is expected to achieve the highest compound annual growth rate (CAGR) and maintain a leading position in the allergy immunotherapy market during the forecast period. This growth is supported by the active presence of major industry participants, including ASIT Biotech, Circassia, Mylan N.V., and Merck KGaA. Currently, allergic conditions affect over 150 million individuals across the region. By 2025, it is projected that more than half of Europe's population will experience some form of allergy, a trend largely driven by industrialization, urbanization, climate change, and escalating pollution levels.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1924

Recent Developments:
• In July 2022, The good findings regarding the significant advantage of sublingual liquid allergen immunotherapy treatment (AIT) on the beginning and worsening of asthma in patients with allergic rhinitis was released by Stallergenes Greer, a worldwide healthcare firm that specializes in allergen immunotherapy (AIT).

Segmentation of Allergy Immunotherapy Market-
By Treatment Type-
• Subcutaneous Immunotherapy (SCIT)
• Sublingual Immunotherapy (SLIT)
• Tablets
• Drops
By Allergy Type-
• Allergic rhinitis
• Allergic asthma
• Others
By Distribution Channel-
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa

Read Overview Report- https://www.insightaceanalytic.com/report/allergy-immunotherapy-market-/1924

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.